Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 8/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.41 |
| ▸ | TP53 | P04637 | 3/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 3/20 | 0.39 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL236551 | 0.85 | TSHR (0.52) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL105934 | 0.85 | TSHR (0.46) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL21811200 | 0.84 | TSHR (0.47) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL109189 | 0.82 | TSHR (0.47) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL332972 | 0.82 | TSHR (0.47) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL16537445 | 0.81 | TSHR (0.43) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL673300 | 0.81 | TSHR (0.52) | TSHRHPGDALDH1A1TP53HIF1A | |
| Propane SCHEMBL28656089 | 0.81 | TSHR (0.46) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL227221 | 0.80 | TSHR (0.42) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL27853675 | 0.80 | TSHR (0.42) | TSHRHPGDALDH1A1TP53HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 164 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117388335-A | Semi-solid reference electrode of sodium ion battery for vehicle and preparation method thereof | 浙江华宇钠电新能源科技有限公司 | 2024-01-12 | — | — | CN | claimed |
| EP-4035649-B1 | DENTAL ADHESIVE COMPOSITION | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2023-07-26 | — | — | EP | claimed |
| EP-4035649-A1 | DENTAL ADHESIVE COMPOSITION | 3M Innovative Properties Company (US) | 2022-08-03 | — | — | EP | claimed |
| CN-111038079-B | Water-based elastic pyrograph process without adhesive edge | 浙江森马服饰股份有限公司 | 2021-11-19 | — | — | CN | claimed |
| CN-111038079-A | Water-based elastic pyrograph process without adhesive edge | 浙江森马服饰股份有限公司 | 2020-04-21 | — | — | CN | claimed |
| EP-1833865-A1 | CROSS-LINKABLE, SILANE-MODIFIED COPOLYMERS | Consortium für elektrochemische Industrie GmbH (DE) | 2007-09-19 | — | — | EP | claimed |
| WO-2006072411-A1 | CROSS-LINKABLE, SILANE-MODIFIED COPOLYMERS | WACKER CHEMIE AG (DE) | 2006-07-13 | — | — | WO | claimed |
| US-6841694-B2 | Process for stabilizing unsaturated organosilicon compounds | WACKER-CHEMIE GMBH (DE) | 2005-01-11 | — | — | US | claimed |
| US-20040171859-A1 | Process for stabilizing unsaturated organosilicon compounds | WACKER-CHEMIE GMBH (DE) | 2004-09-02 | — | — | US | claimed |
| US-20260028440-A1 | Curable Composition for Producing Transparent Orthodontic Attachments | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2026-01-29 | — | — | US | disclosed |
| EP-4622590-A1 | CURABLE COMPOSITION FOR USE IN A PROCESS OF TREATING A DENTAL SITUATION IN THE MOUTH OF A PATIENT | Solventum Intellectual Properties Company (US) | 2025-10-01 | — | — | EP | disclosed |
| EP-4558086-A1 | CURABLE COMPOSITION FOR PRODUCING TRANSPARENT ORTHODONTIC ATTACHMENTS | Solventum Intellectual Properties Company (US) | 2025-05-28 | — | — | EP | disclosed |
| CN-119584936-A | Curable composition for producing transparent orthodontic accessories | 舒万诺知识产权公司 | 2025-03-07 | — | — | CN | disclosed |
| US-12240868-B2 | Organic silicon compound and production method therefor | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2025-03-04 | — | — | US | disclosed |
| US-20020151736-A1 | PROCESS FOR PREPARING UNSATURATED ORGANOSILICON COMPOUNDS | WACKER-CHEMIE GMBH (DE) | 2002-10-17 | — | — | US | disclosed |
| EP-1249454-A1 | Preparation of unsaturated organo-silicon compounds | Wacker-Chemie GmbH (DE) | 2002-10-16 | — | — | EP | disclosed |
| US-20010053813-A1 | Rubber compositions | JSR CORPORATION (JP) | 2001-12-20 | — | — | US | disclosed |
| EP-0486279-B2 | Process for removing acidic impurities from alkoxysilanes | SHINETSU CHEMICAL CO (JP) | 1999-12-01 | — | — | EP | disclosed |
| US-5247117-A | Neutralization with sterically hindered alcohols or amines, distillation | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1993-09-21 | — | — | US | disclosed |
| EP-0486279-A1 | Process for removing acidic impurities from alkoxysilanes | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1992-05-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040171859-A1 | Process for stabilizing unsaturated organosilicon compounds | ELOVL1, ELOVL6, DEGS1 | TSHR 4650/4885HPGD 1893/4885ALDH1A1 402/4885 |
| US-20260028440-A1 | Curable Composition for Producing Transparent Orthodontic Attachments | SMCHD1, SMC2, SMC1A | TSHR 705/4885HPGD 4304/4885ALDH1A1 1413/4885 |
| US-12240868-B2 | Organic silicon compound and production method therefor | OR51E2, MSL1, SOS1 | TSHR 4456/4885HPGD 4522/4885ALDH1A1 2353/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.